Top Markets
Coin of the day
YD Bio Limited Ordinary Shares YD Bio Limited Ordinary Shares

YD Bio Limited Ordinary Shares

YDES
Rank in Stocks #19456
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company... Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.
Share Price
$2.28
Last synced: 2026-07-31
Market Cap
$161.59M
Change (1 day)
3.70%
Change (1 year)
-82.92%
Country
TW
Trade YD Bio Limited Ordinary Shares (YDES)

Category

Earnings for YD Bio Limited Ordinary Shares (YDES)
Earnings in 2026 TTM: 0
According to YD Bio Limited Ordinary Shares latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for YD Bio Limited Ordinary Shares from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$5.27B -
US
$1.95B -
NL
$-3.09B -
US
$-4.02B -
AU
- -
CH